There was no overlap between BRAF(V599E) mutation and RET/PTC rearrangements.     ///    (1) BRAF(V599E) mutation and RET/PTC rearrangements were unique to PTC.     ///    (3) There was no overlap between BRAF(V599E) mutation and RET/PTC rearrangements suggest that they are alternative events in PTC..     ///    [BRAFV599E mutation and RET/PTC rearrangements in papillary thyroid carcinoma].     ///    [BRAFV599E mutation and RET/PTC rearrangements in papillary thyroid carcinoma]..     ///    "(3) Statistic data did not show any correlation between the BRAF(V599E) mutation, RET/PTC and clinicopathologic features of PTC (P > 0.05). "    ///    "Among them, 5 cases (7.6%) were RET/PTC1 and 9 cases (13.6%) were RET/PTC3 respectively. "    ///    (2) Fourteen (21.2%) PTC cases expressed RET/PTC chimeric gene.     ///    PCR and RT-PCR were employed to detect BRAF(V599E) mutation and RET/PTC chimeric genes in 95 frozen and parraffine-embeded thyroid tissue. 